CareDx Q4 rev $108M +25% YoY, FY25 rev $380M; FY26 guide $420-444M; CFO resigns, Kennedy appointed

CareDx, Inc.

2025-FY EPS reported -$0.40 revenue$379,805,000

Q4 revenue $108M (+25% YoY); full-year revenue $380M (+14%). FY2026 guidance $420-444M.
Q4 GAAP net loss $4M vs $88M income (prior year had $96M litigation reversal); FY25 GAAP loss $21M; adj. EBITDA $32M.
Testing services Q4 rev $78M (+23%), volume ~53K tests (+17%); full-year rev $275M.
CFO Nathan Smith resigns for personal reasons; Keith Kennedy (COO since Sept 2024) appointed CFO & COO effective Feb 26.
Smith separation: 9 months base salary, $91,643 bonus, COBRA reimbursement, and 5,840 RSUs vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.